Improvement of constrictive bronchiolitis (bronchiolitis obliterans) after rituximab therapy in 2 patients with primary sjögren syndrome

Garcia-Carrasco, 2002, Primary Sjogren syndrome: clinical and immunologic disease patterns in a cohort of 400 patients, Medicine (Baltim.), 81, 270, 10.1097/00005792-200207000-00003 Mariette, 2018, Primary sjogren's syndrome, N. Engl. J. Med., 379, 97 Shiboski, 2017, Sjogren's Syndrome Criteria Working, 2016 American College of Rheumatology/European League against Rheumatism classification criteria for primary Sjogren's syndrome: a consensus and data-driven methodology involving three international patient cohorts, Ann. Rheum. Dis., 76, 9, 10.1136/annrheumdis-2016-210571 Nakanishi, 2011, Small airway disease associated with Sjogren's syndrome: clinico-pathological correlations, Respir. Med., 105, 1931, 10.1016/j.rmed.2011.08.009 Wight, 2019, Constrictive bronchiolitis in patients with primary sjogren syndrome, J. Clin. Rheumatol., 25, 74, 10.1097/RHU.0000000000000771 Natalini, 2019, Pulmonary involvement in sjogren syndrome, Clin. Chest Med., 40, 531, 10.1016/j.ccm.2019.05.002 Flament, 2016, Pulmonary manifestations of Sjogren's syndrome, Eur. Respir. Rev., 25, 110, 10.1183/16000617.0011-2016 Constantopoulos, 1985, Respiratory manifestations in primary Sjogren's syndrome. A clinical, functional, and histologic study, Chest, 88, 226, 10.1378/chest.88.2.226 Lahdensuo, 1995, Pulmonary findings in patients with primary Sjogren's syndrome, Chest, 108, 316, 10.1378/chest.108.2.316 Franquet, 1997, Primary Sjogren's syndrome and associated lung disease: CT findings in 50 patients, AJR Am. J. Roentgenol., 169, 655, 10.2214/ajr.169.3.9275871 Devauchelle-Pensec, 2007, Improvement of Sjogren's syndrome after two infusions of rituximab (anti-CD20), Arthritis Rheum., 57, 310, 10.1002/art.22536 Seror, 2007, Tolerance and efficacy of rituximab and changes in serum B cell biomarkers in patients with systemic complications of primary Sjogren's syndrome, Ann. Rheum. Dis., 66, 351, 10.1136/ard.2006.057919 Pijpe, 2005, Rituximab treatment in patients with primary Sjogren's syndrome: an open-label phase II study, Arthritis Rheum., 52, 2740, 10.1002/art.21260 Devauchelle-Pensec, 2014, Treatment of primary Sjogren syndrome with rituximab: a randomized trial, Ann. Intern. Med., 160, 233, 10.7326/M13-1085 Hutchinson, 2016, In-hospital mortality after surgical lung biopsy for interstitial lung disease in the United States. 2000 to 2011, Am. J. Respir. Crit. Care Med., 193, 1161, 10.1164/rccm.201508-1632OC Gottenberg, 2005, Correlation of serum B lymphocyte stimulator and beta2 microglobulin with autoantibody secretion and systemic involvement in primary Sjogren's syndrome, Ann. Rheum. Dis., 64, 1050, 10.1136/ard.2004.030643 Theander, 2006, Lymphoma and other malignancies in primary Sjogren's syndrome: a cohort study on cancer incidence and lymphoma predictors, Ann. Rheum. Dis., 65, 796, 10.1136/ard.2005.041186 Ramos-Casals, 2012, Topical and systemic medications for the treatment of primary Sjogren's syndrome, Nat. Rev. Rheumatol., 8, 399, 10.1038/nrrheum.2012.53 Meijer, 2010, Effectiveness of rituximab treatment in primary Sjogren's syndrome: a randomized, double-blind, placebo-controlled trial, Arthritis Rheum., 62, 960, 10.1002/art.27314 Meijer, 2009, Treatment of primary Sjogren syndrome with rituximab: extended follow-up, safety and efficacy of retreatment, Ann. Rheum. Dis., 68, 284, 10.1136/ard.2008.092601 Gottenberg, 2013, Efficacy of rituximab in systemic manifestations of primary Sjogren's syndrome: results in 78 patients of the AutoImmune and Rituximab registry, Ann. Rheum. Dis., 72, 1026, 10.1136/annrheumdis-2012-202293